FilingSEC EDGAR8-K
Lexaria Bioscience Secures $5.9M via Warrant Exercise
· SEC accepted
StageCompleted
Filing content
The company entered into agreements to induce the early exercise of existing warrants at a reduced price of $12.92 per share, expecting $5.9 million in gross proceeds.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…